B. Pelak

发表

Difficidin and oxydifficidin: novel broad spectrum antibacterial antibiotics produced by Bacillus subtilis. I. Production, taxonomy and antibacterial activity.

E. C. Gilfillan, S. Zimmerman, C. Schwartz, 1987, The Journal of antibiotics.

In Vivo Activity and Pharmacokinetic Evaluation of a Novel Long-Acting Carbapenem Antibiotic, MK-826 (L-749,345)

B. Pelak, C. Gill, H. Rosen, 1998, Antimicrobial Agents and Chemotherapy.

Comparative in vitro activities of ertapenem against bacterial pathogens from patients with acute pelvic infection.

H. Teppler, E. Goldstein, M. Motyl, 2002, The Journal of antimicrobial chemotherapy.

QUATERNARY HETEROCYCLYLAMINO β-LACTAMS

E. C. Gilfillan, B. Pelak, B. Weissberger, 1987 .

Quaternary heterocyclylamino beta-lactams. VI. In vitro and in vivo antibacterial properties of L-642,946 and L-652,813, a long acting cephem.

E. C. Gilfillan, B. Pelak, B. Weissberger, 1987, The Journal of antibiotics.

Quaternary heterocyclylamino beta-lactams. III. The mode of action of L-640,876 and the effect of NaCl on membrane permeability and binding.

B. Pelak, L. Koupal, P. Cassidy, 1983, The Journal of antibiotics.

Development of the semisynthetic cephamycin, cefoxitin, as a clinical candidate

H. B. Woodruff, S. Zimmerman, B. Pelak, 2005, Infection.

Efficacy of Caspofungin against Aspergillus flavus, Aspergillus terreus, and Aspergillus nidulans

P. Liberator, B. Pelak, C. Gill, 2006, Antimicrobial Agents and Chemotherapy.

Preliminary animal pharmacokinetics of the parenteral antifungal agent MK-0991 (L-743,872)

H Kropp, B. Pelak, J. Dropinski, 1997, Antimicrobial agents and chemotherapy.

Antibacterial Agents That Inhibit Lipid A Biosynthesis

A. Patchett, M. Anderson, H. Onishi, 1996, Science.

Reduced immunotoxicity and preservation of antibacterial activity in a releasable side-chain carbapenem antibiotic.

H. Rosen, J. Heck, J. Kozarich, 1999, Science.

Cefoxitin, a Semisynthetic Cephamycin Antibiotic: In Vivo Evaluation

B. Pelak, E. Stapley, D. Hendlin, 1974, Antimicrobial Agents and Chemotherapy.

(Acyloxy)alkyl carbamate prodrugs of norfloxacin.

R. Fromtling, B. Pelak, J. Bland, 1991, Journal of medicinal chemistry.

Mode of Action of β‐Lactone 1233A in Candida albicans

G. Garrity, R. Fromtling, B. Pelak, 1988 .

Mode Of Action of L‐660,631 in Candida albicans

G. Garrity, R. Fromtling, B. Pelak, 1988 .

Comparative in vitro activity of ertapenem against bacterial pathogens isolated from patients with lower respiratory tract infections.

M. Motyl, G. Woods, B. Pelak, 2002, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Comparative in vitro activities of ertapenem against aerobic and facultative bacterial pathogens from patients with complicated skin and skin structure infections.

M. Motyl, G. Woods, R. Gesser, 2002, Diagnostic microbiology and infectious disease.

Comparative In-Vitro Activities of Ertapenem against Aerobic Bacterial Pathogens Isolated from Patients with Complicated Intra-abdominal Infections

H. Teppler, M. Motyl, G. Woods, 2002, Journal of chemotherapy.

Pharmacokinetic studies of norfloxacin in laboratory animals.

E. C. Gilfillan, B. Pelak, P. Malatesta, 1984, Chemotherapy.

Cephamycins, a New Family of β-Lactam Antibiotics. IV. In Vivo Studies

B. Pelak, E. Stapley, H. Kropp, 1972, Antimicrobial Agents and Chemotherapy.

Difficidin and oxydifficidin: novel broad spectrum antibacterial antibiotics produced by Bacillus subtilis. II. Isolation and physico-chemical characterization.

J. L. Smith, R. Schwartz, O. Hensens, 1987, The Journal of antibiotics.